Direkt zum Inhalt
  1. Publizieren |
  2. Suche |
  3. Browsen |
  4. Neuzugänge rss |
  5. Open Access |
  6. Rechtsfragen |
  7. EnglishCookie löschen - von nun an wird die Spracheinstellung Ihres Browsers verwendet.

Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients

Hundeshagen, Gabriel ; Herndon, David N. ; Capek, Karel D. ; Branski, Ludwik K. ; Voigt, Charles D. ; Killion, Elizabeth A. ; Cambiaso-Daniel, Janos ; Sljivich, Michaela ; De Crescenzo, Andrew ; Mlcak, Ronald P. ; Kinsky, Michael P. ; Finnerty, Celeste C. ; Norbury, William B.

In: Critical care, 21 (2017), Nr. 318. S. 1-10. ISSN 1466-609X

[thumbnail of 13054_2017_Article_1899.pdf]
Vorschau
PDF, Englisch
Download (791kB) | Lizenz: Creative Commons LizenzvertragCo-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients von Hundeshagen, Gabriel ; Herndon, David N. ; Capek, Karel D. ; Branski, Ludwik K. ; Voigt, Charles D. ; Killion, Elizabeth A. ; Cambiaso-Daniel, Janos ; Sljivich, Michaela ; De Crescenzo, Andrew ; Mlcak, Ronald P. ; Kinsky, Michael P. ; Finnerty, Celeste C. ; Norbury, William B. steht unter einer Creative Commons Namensnennung 4.0

Zitieren von Dokumenten: Bitte verwenden Sie für Zitate nicht die URL in der Adresszeile Ihres Webbrowsers, sondern entweder die angegebene DOI, URN oder die persistente URL, deren langfristige Verfügbarkeit wir garantieren. [mehr ...]

Abstract

Background: Burn patients are prone to infections which often necessitate broad antibiotic coverage. Vancomycin is a common antibiotic after burn injury and is administered alone (V), or in combination with imipenem-cilastin (V/IC) or piperacillin-tazobactam (V/PT). Sparse reports indicate that the combination V/PT is associated with increased renal dysfunction. The purpose of this study was to evaluate the short-term impact of the three antibiotic administration types on renal dysfunction.

Methods: All pediatric and adult patients admitted to our centers between 2004 and 2016 with a burn injury were included in this retrospective review if they met the criteria of exposition to either V, V/IC, or V/PT for at least 48 h, had normal baseline creatinine, and no pre-existing renal dysfunction. Creatinine was monitored for 7 days after initial exposure; the absolute and relative increase was calculated, and patient renal outcomes were classified according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria depending on creatinine increases and estimated creatinine clearance. Secondary endpoints (demographic and clinical data, incidences of septicemia, and renal replacement therapy) were analyzed. Antibiotic doses were modeled in logistic and linear multivariable regression models to predict categorical KDIGO events and relative creatinine increase.

Results: Out of 1449 patients who were screened, 718 met the inclusion criteria, 246 were adults, and 472 were children. Between the study cohorts V, V/IC, and V/PT, patient characteristics at admission were comparable. V/PT administration was associated with a statistically higher serum creatinine, and lower creatinine clearance compared to patients receiving V alone or V/IC in adults and children after burn injury. The incidence of KDIGO stages 1, 2, and 3 was higher after V/PT treatment. In children, the incidence of KDIGO stage 3 following administration of V/PT was greater than after V/IC. In adults, the incidence of renal replacement therapy was higher after V/PT compared with V or V/IC. Multivariate modeling demonstrated that V/PT is an independent predictor of renal dysfunction.

Conclusion: Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in pediatric and adult burn patients when compared to vancomycin alone or vancomycin plus imipenem-cilastin. The mechanism of this increased nephrotoxicity remains elusive and warrants further scientific evaluation.

Dokumententyp: Artikel
Titel der Zeitschrift: Critical care
Band: 21
Nummer: 318
Verlag: BioMed Central ; Springer
Ort der Veröffentlichung: London ; Berlin ; Heidelberg
Erstellungsdatum: 02 Mai 2018 07:40
Erscheinungsjahr: 2017
ISSN: 1466-609X
Seitenbereich: S. 1-10
Institute/Einrichtungen: Medizinische Fakultät Mannheim > Chirurgische Klinik
DDC-Sachgruppe: 610 Medizin
Leitlinien | Häufige Fragen | Kontakt | Impressum |
OA-LogoDINI-Zertifikat 2013Logo der Open-Archives-Initiative